The companies we have invested in.

CLD-9 uses robotics to make personalized medicine scalable, precision formulation built to serve tens of thousands of people a month as it scales.

Agencity's role: Early investor, in before Antler and Boost VC, and ran the company's $2M fundraise end to end. Today the firm operates the company's entire growth funnel through a team it built and runs across India and the US, has closed commercial deals for the company in both markets, and opened the Gulf through its operators there, including representing the company to investors and partners in Abu Dhabi.

Biomimetic, mussel-inspired polymer chemistry that bonds and coats on wet and submerged surfaces, where conventional adhesives fail. Applications span defense (US Navy contracts), dental, biomedical, and industrial repair. The company closed a $10M Series A.

Agencity's role: Investor in the Series A. We are in active conversations to bring Mussel into India through the firm's channels, beginning with the pool-coating and water-feature repair vertical routed through our real-estate relationships.

The fundraising platform for founders: identifies the investors most likely to fund a round using live behavioral signals, automates outreach personalized to each investor's thesis, and manages the raise through to close.

Agencity's role: Investor (July 2026). Raisi's founder wrote publicly: “Arjun Vad is a prime example of an investor who goes far beyond writing a check.”

Nuron builds world models: AI systems that learn a compact internal representation of the world from video and predict how it evolves. The lab is in stealth, and that is deliberate.

Agencity's role: Founding partner.